REGCP Regency delivers 153 percent Q4 2025 EPS surprise shares rise 104 percent on strong quarterly results Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline USPH US stock slips 165 after Q4 2025 EPS posts a narrow 15 miss against analyst estimates